OneMedNet (NASDAQ:ONMD) CEO Aaron Green Sells 5,000 Shares of Stock

OneMedNet Corporation (NASDAQ:ONMD) CEO Aaron Green sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, September 22nd. The shares were sold at an average price of $7.39, for a total value of $36,950.00. Following the completion of the sale, the chief executive officer directly owned 249,638 shares in the company, valued at approximately $1,844,824.82. This represents a 1.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Aaron Green also recently made the following trade(s):

• On Thursday, September 24th, Aaron Green sold 1,667 shares of OneMedNet stock. The stock was sold at an average price of $6.48, for a total value of $10,802.16.

OneMedNet Stock Performance

NASDAQ ONMD opened at $4.30 on Friday. The stock has a 50-day simple moving average of $6.24 and a 200 day simple moving average of $7.32. OneMedNet Corporation has a twelve month low of $4.30 and a twelve month high of $42.20. The stock has a market capitalization of $25.50 million, a PE ratio of -2.69 and a beta of 1.14.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 24th. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.